<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01145339</url>
  </required_header>
  <id_info>
    <org_study_id>EF099</org_study_id>
    <nct_id>NCT01145339</nct_id>
  </id_info>
  <brief_title>A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI)</brief_title>
  <acronym>EF099</acronym>
  <official_title>A Phase III, Non-Inferiority, Randomized, Double-Blind, Parallel-Group, Multicentre, Single-Dose, Comparative Clinical Study of Lactase Eurofarma (Test Drug) and Lactaid® (Comparative Drug), Assessing the Efficacy and Safety in the Treatment of Patients With Lactose Intolerance (Hypolactasia)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eurofarma Laboratorios S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eurofarma Laboratorios S.A.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study primary objective is to compare the clinical efficacy of two formulations in the
      supportive treatment of lactose intolerance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hydrogen value in the air expired</measure>
    <time_frame>03 times</time_frame>
    <description>Hydrogen value in the expired air for 3h after the patient exposure to the standardized Lactose 25g dose with interventional exogenous Lactase (comparative and test drugs).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Hypolactasia</condition>
  <arm_group>
    <arm_group_label>Lactase EUF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 chewable tablet of the test drug 30 minutes before the standard lactose dose (25 g).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lactase Ref</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 chewable tablet of the comparative drug 30 minutes before the standard lactose dose (25 g).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactase</intervention_name>
    <description>1 chewable tablet of the test drug or comparative drug 30 minutes before the standard lactose dose (25 g).</description>
    <arm_group_label>Lactase EUF</arm_group_label>
    <arm_group_label>Lactase Ref</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient should be a male or female, aged between 18 and 60 years old;

          2. Have a medical history consistent with lactose intolerance, confirmed by the test of
             hydrogen in the expired air;

          3. The female patients should agree to use birth control methods during the study
             participation;

          4. To be able to meet the study instructions and all the visits required;

          5. To give a free consent to participate in the study and sign the informed consent form
             (ICF).

        Exclusion Criteria:

          1. Smoking;

          2. Secondary hypolactasia;

          3. Gastrointestinal inflammatories diseases - present diverticular disease, diabetic
             gastropathy or neoplasias;

          4. Colonoscopy or colon cleaning procedure 4 weeks before the start of study

          5. Latrogenic: unnoticed intake of laxatives in over-the-counter drugs or alternative
             medicine, intake of cereal bran or probiotics;

          6. Diagnosis of HIV, immunodepression of any origin, or cancer under treatment.

          7. Diagnosis of other comorbidity that, at the investigator's discretion, may compromise
             the study participation (e.g., systemic infection during the study or use of
             antibiotics in the last 4 weeks, diabetes mellitus, uncontrolled hypertension or renal
             failure),

          8. Hypersensitivity or previous laboratory or clinical adverse event related to the use
             of lactase or any of the components of the formulations used in the study;

          9. Incapacity to understand and complete the study questionnaires, including the
             questions that require the use of the Visual Analogue Scale and ICF;

         10. Pregnancy or lactation;

         11. Use of alcohol, exceeding 3 doses daily;

         12. Participation in another clinical study on the last 12 months;

         13. Patient having some chronic pulmonary disease that, in the investigator's opinion, may
             harm or interfere with the expired hydrogen test (e.g., cystic fibrosis).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aderson Damião, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital das Clínicas de São Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heda Amarante, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Nossa Senhora das Graças</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marta Machado, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital São Lucas PUCRS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sender Miszputen, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital São Paulo / UNIFESP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wilson Catapani, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculdade de Medicina do ABC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mauro Bafutto, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Goiano de Gastroenterologia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos Francesconi, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Mãe de Deus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria do Carmo Passos, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Alfa de Gastroenterologia de BH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Instituto Goiano de Gastroenterologia</name>
      <address>
        <city>Goiania</city>
        <state>GO</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Alfa de Gastroenterologia</name>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nossa Senhora das Graças</name>
      <address>
        <city>Curitiba</city>
        <state>PR</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital São Lucas</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90610-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Mãe de Deus</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Faculdade de Medicina do ABC</name>
      <address>
        <city>Santo André</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital São Paulo / UNIFESP</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2010</study_first_submitted>
  <study_first_submitted_qc>June 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2010</study_first_posted>
  <last_update_submitted>June 22, 2012</last_update_submitted>
  <last_update_submitted_qc>June 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lactose Intolerance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

